Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Operating Income ContractionContracting
Percentile Rank13
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-37.34M
↓ 19% vs avg
Percentile
P13
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-31.25M
Historical baseline
PeriodValueYoY Change
TTM$-37.34M+11.4%
2024$-42.12M+18.9%
2023$-51.92M-52.2%
2022$-34.10M-36.6%
2021$-24.96M-11.5%
2020$-22.39M-1.5%
2019$-22.07M+7.4%
2018$-23.83M+11.5%
2017$-26.91M-0.2%
2016$-26.85M-